Infectious Diseases Academic Physician, COVID Infection Prevention Expert
Johns Hopkins School of Medicine
Clare Rock, M.D., M.S., is an Associate Professor of Medicine, Division of Infectious Disease, Armstrong Institute of Patient Safety and Quality Core Faculty, and Healthcare Epidemiologist, Johns Hopkins University School of Medicine. Dr. Rock is an infectious disease academic physician who innovatively translates healthcare infection prevention to the business, travel & hospitality, and event management industries, guiding through COVID-19 pandemic to the “Next New Normal”. Dr. Rock owns and directs Infection Prevention Strategy Consulting LLC, and consults for Johns Hopkins Medicine International. Clients include major international hospitality and travel brands, with properties and destinations in over 50 countries. Dr. Rock is the principal investigator of CDC-funded research studies including innovation with COVID-19 respirators/face masks, testing & vaccination strategies, and translation of physical distancing practices into the workplace. She co-leads a public health-academic partnership including Johns Hopkins School of Medicine and Maryland Department of Health; Statewide Prevention and Reduction Collaborative (SPARC), reducing COVID-19 healthcare-associated transmissions across the state. She has over 50 peer-reviewed published academic manuscript publications, multiple media (video & print) appearances including PBS NewsHour, and is an elected councilor on the Society of Healthcare Epidemiology of America (SHEA) board of trustees, past Chair of SHEA Research Network, and a research co-director of the High-Value Practice Academic Alliance. Dr. Rock’s unique skillset of infection prevention science, public health, infectious disease research, change management, implementation science, with an understanding of the world of business, position her to give sound proactive business advice. Specific areas include COVID-19 testing strategies for the workplace, businesses, integrated testing/vaccination strategies for event management, return to work policies, return to business strategies, outbreak and cluster management, contact tracing, addressing COVID-19 vaccine hesitancy in the workplace and the community.
The COVID-19 pandemic has clearly shown me that there is a need for translation of infection prevention expertise from the healthcare setting into businesses, industries, workplaces, and event management strategies, to guide these industries through the pandemic and into their “Next New Normal”.
Integration of strategic infection prevention/public health experts into the executive suites of large corporations. Defining and safely transitioning businesses, communities, gatherings including sports, travel, hospitality to the “Next New Normal”.
"Prevention is better than cure". I advised on outbreak management in workplaces to prevent the further spread of COVID-19 infection to other employees or clients. Proactively forming safe strategies to allow businesses to perform essential money-generating tasks.
Employee wellness programs.
Integrating my consulting company Infection Prevention Strategy Consulting LLC into executive leadership business strategies.
The COVID-19 pandemic has caused a significant shift in employee’s perceptions and expectations for corporate companies. After more than 1 year of working remotely, those who return full-time or in hybrid to physical working space will be nervous, anxious, will have many questions, and expect their employer to address these issues proactively. There will be a significant need for guidance from trusted Infection Prevention experts in the short and long term as this landscape changes forever.
Webinars to large corporate audiences with education related to COVID-19 workplace strategies, vaccination/testing strategies, and predictions for pandemic.
Integrating strategic infection prevention/public health experts into executive teams is a proactive strategy to reduce costs, focus on culture and let employees know you care.